✦ LIBER ✦

The FDA perspective on the development of stereoisomers

✍ Scribed by Wilson H. De Camp

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of compliance on drug development

✍ M Cavaillé-Coll 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Toxicity Testing: The FDA Perspective

✍ JANE E. HENNEY 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Endovascular brachytherapy: The FDA's pe

✍ Tara A. Ryan 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 190 KB

VARC Consensus Report: The FDA Perspecti

✍ Matthew G. Hillebrenner; Julie A. Swain; Bram Zuckerman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 84 KB

8 The FDA perspective on marketing appro

✍ A. Farrell 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Ethical Perspectives on the FDA and ADA

✍ Robert M. Veatch PhD 📂 Article 📅 1992 🏛 American Association of Public Health Dentistry 🌐 English ⚖ 513 KB